Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 6Depression 4Uterine Cervical Neoplasms 2Urinary Bladder Neoplasms 2Triple Negative Breast Neoplasms 2Thyroid Neoplasms 2Prostatic Neoplasms 2Lymphoma, Non-Hodgkin 2Lymphoma, Mantle-Cell 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Follicular 2Lymphoma 2Head and Neck Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Burkitt Lymphoma 2Anxiety Disorders 2Urologic Diseases 1Treatment Adherence and Compliance 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Smoking Cessation 1Sarcoma 1Radiation Fibrosis Syndrome 1Pyloric Stenosis, Hypertrophic 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Postoperative Hemorrhage 1Peripheral Lung Tumor 1Patient Acceptance of Health Care 1Obesity 1Neoplasm Metastasis 1

Interventions

Therapeutics 168Ga-FAPI 12-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × 177Lu-EB-FAPI × Therapeutics × Clear all
NCT05400967 2024-09-19

Diagnosis of Metastatic Tumors on 68Ga-FAPI PET-CT and Radioligand Therapy with 177Lu-EB-FAPI

Peking Union Medical College Hospital

Phase EARLY_PHASE1 Recruiting
10 enrolled

177Lu-EB-FAPI

Data powered by HemOnc (CC BY 4.0) Colophon âš¡